| | | 00703 | | 13.02.2007 | | MSD Merck Sharp & Dohme AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | M-M-RVAXPRO | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | () + Lyophilisate and solvent (Virus Morbilli Vivus (Stamm Edmonston-Enders) 1000 U, Virus Parotitis Vivus (Stamm Jeryl Lynn) 12500 U, Virus Rubella Vivus (Stamm Wistar ra 27/3) 1000 U) + () | J07BD52 | | | 02 | MMRvaxPRO | | (Virus Morbilli Vivus (Stamm: Ender´s Edmonston) 0 U, Virus Parotitis Vivus (Stamm: Jeryl lynn (Level B)) 0 U, Vaccinum Rubellae Vivum Attenuatum (Cellulae Hdc), Wistar ra 27/3 0 U) | | | | 03 | MMRvaxPRO | | (Virus Morbilli Vivus (Stamm: Ender's Edmonston) 0 U, Virus Parotitis Vivus (Stamm: Jeryl lynn (Level B)) 0 U, Virus Rubella Vivus (Stamm Wistar ra 27/3) 0 U) | | |
|
|
